Company Filing History:
Years Active: 2015
Title: Vincenzo Calderone: Innovator in Selective COX-2 Inhibitors
Introduction
Vincenzo Calderone is a notable inventor based in Massa, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective COX-2 inhibitors. His innovative work has the potential to improve therapeutic outcomes while minimizing side effects.
Latest Patents
Calderone holds a patent for a compound titled "1,5-Diaryl-2-alkylpyrrole-3-substituted nitro esters." This invention focuses on selective COX-2 inhibitors that also act as nitric oxide donors. The compounds described in his patent are designed to release nitric oxide in concentrations that can mitigate the side effects associated with selective COX-2 inhibition, without causing hypotensive effects. The formula includes various substituents that enhance the efficacy and safety of these compounds.
Career Highlights
Calderone is associated with Rottapharm Biotech S.r.l., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in pharmaceutical formulations and methods of use. His contributions have the potential to impact the treatment of various conditions that require COX-2 inhibition.
Collaborations
Calderone has collaborated with notable colleagues such as Antonio Giordani and Mariangela Biava. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Vincenzo Calderone's work in the field of selective COX-2 inhibitors represents a significant advancement in pharmaceutical science. His innovative compounds have the potential to improve patient outcomes while reducing adverse effects.